Related Experiment Video
Updated: May 4, 2026
03:50
Author Spotlight: Effectiveness of Extracorporeal Shockwave Therapy in Achilles Tendinopathy Treatment
Published on: August 2, 2024
2.5K
[Technical improvements and clinical study for extracorporeal shock wave lithotriptor].
1Shenzhen New Element Medical Equipment Technology Development Co. Ltd., Shenzhen, 518029. jiangfengqing@szxys.cn
Summary
The upgraded XYS.SUI-6X extracorporeal shock wave lithotriptor shows improved clinical efficacy. This advanced lithotripter achieved a 96.67% total cure and relief rate in clinical trials.
Area of Science:
- Urology
- Medical Devices
- Nephrology
Context:
- Extracorporeal shock wave lithotripsy (ESWL) is a common treatment for kidney stones.
- Previous generations of lithotripters have varying success rates.
- Technical advancements in ESWL devices are crucial for improving patient outcomes.
Purpose:
- To review technical improvements in the XYS.SUI-6X extracorporeal shock wave lithotriptor.
- To evaluate the clinical efficacy of the upgraded XYS.SUI-6X lithotriptor through a clinical study.
- To compare the outcomes of the upgraded device with its pre-improvement performance.
Summary:
- The XYS.SUI-6X lithotriptor underwent technical upgrades.
- A clinical trial demonstrated increased curative and effective ratios post-upgrade, reaching 76.67% and 20.00% respectively.
- The total cure and relief rate was 96.67%, with an invalidation rate of 3.33%, indicating superior results compared to the previous version.
Impact:
- The improved XYS.SUI-6X lithotriptor offers enhanced treatment effectiveness for kidney stones.
- These advancements contribute to better patient outcomes and potentially reduced treatment failures.
- The study highlights the significance of continuous technological development in ESWL therapy.
